Retrophin, Inc. Underwriting Agreements

8 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Underwriting Agreement between Travere Therapeutics, Inc. and Jefferies LLC and Leerink Partners LLC (November 2024)
Underwriting Agreements
Retrophin, Inc.
Biotechnology
NY
2024
Underwriting Agreement between Travere Therapeutics, Inc. and Jefferies LLC, J.P. Morgan Securities LLC, BofA Securities, Inc., and SVB Securities LLC (February 28, 2023)
Underwriting Agreements
Retrophin, Inc.
Biotechnology
NY
2023
Underwriting Agreement for $275,000,000 2.25% Convertible Senior Notes due 2029 by Travere Therapeutics, Inc. and Underwriters
Underwriting Agreements
Retrophin, Inc.
Biotechnology
NY
2022
Underwriting Agreement between Travere Therapeutics, Inc. and BofA Securities, Jefferies LLC, and SVB Leerink LLC
Underwriting Agreements
Retrophin, Inc.
Biotechnology
NY
2021
Retrophin, Inc. Underwriting Agreement with Jefferies LLC, Barclays Capital Inc., and BofA Securities, Inc. (June 8, 2020)
Underwriting Agreements
Retrophin, Inc.
Biotechnology
NY
2020
Underwriting Agreement for $240,000,000 2.50% Convertible Senior Notes due 2025 – Retrophin, Inc. and Underwriters (Jefferies LLC, Barclays Capital Inc.)
Underwriting Agreements
Retrophin, Inc.
Biotechnology
2018
Underwriting Agreement between Retrophin, Inc. and Underwriters (Leerink Partners LLC, Deutsche Bank Securities Inc.) for Common Stock Offering
Underwriting Agreements
Retrophin, Inc.
Biotechnology
NY
2015
Retrophin, Inc. Underwriting Agreement with Jefferies LLC for Public Offering of Common Stock
Underwriting Agreements
Retrophin, Inc.
Biotechnology
NY
2014